Back

Jetstream invests in Rejuvenation Technologies to expand access to longevity science

Verifying
  • Jetstream Venture Fund invested in Rejuvenation Technologies.
  • Rejuvenation Technologies has received more than $8 million in non-dilutive grants.
  • The company is developing preclinical treatments for pulmonary fibrosis and chronic liver disease.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.